Evidence map›Paper›PMID 23393319›Full record

Trial reportJournal of the American Society of Nephrology : JASN2013

Risk of vascular access complications with frequent hemodialysis.

Rita S Suri, Brett Larive, Susan Sherer, Paul Eggers, Jennifer Gassman, Sam H James, Robert M Lindsay, Robert S Lockridge, Daniel B Ornt, Michael V Rocco and 3 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Society of Nephrology : JASN, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03239808 (Assessment of the Incremental Haemodialysis Security and Effectiveness in Incident Patients), which is not on this map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03239808 naactive not recruitingnot on this mapstarted 2018, after this paper: background citation

Assessment of the Incremental Haemodialysis Security and Effectiveness in Incident Patients

TypeinterventionalSponsorFundación para la Formación e Investigación de los Profesionales de la Salud de ExtremaduraRan2018 to 2025Enrolled152ConditionsRenal Disease, End-StageArmsIncremental haemodialysis, Conventional haemodialysis
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Home versus in-centre haemodialysis for people with kidney failure.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Interventions for fatigue in people with kidney failure requiring dialysis.The Cochrane database of systematic reviews · 2023
    Pooled it
  3. Home versus in-centre haemodialysis for end-stage kidney disease.The Cochrane database of systematic reviews · 2014
    Pooled it
  4. A Trial of Extending Hemodialysis Hours and Quality of Life.Journal of the American Society of Nephrology : JASN · 2017
    Trial
  5. Trial
  6. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2015
    Trial
  7. Survey of home hemodialysis patients and nursing staff regarding vascular access use and care.Hemodialysis international. International Symposium on Home Hemodialysis · 2015
    Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Patency and effectiveness of vascular access for hemodialysis patients: a descriptive study.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2025
    Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Rita S SuriKidney Clinical Research Unit, University of Western Ontario, Room A2-346, Victoria Hospital, 800 Commissioners Road East, London, Ontario N6A 4G5, Canada. rita.suri@lhsc.on.ca
Brett Larive
Susan Sherer
Paul Eggers
Jennifer Gassman
Sam H James
Robert M Lindsay
Robert S Lockridge
Daniel B Ornt
Michael V Rocco
George O Ting
Alan S Kliger
Frequent Hemodialysis Network Trial Group

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Frequent hemodialysis requires using the vascular access more often than with conventional hemodialysis, but whether this increases the risk for access-related complications is unknown. In two separate trials, we randomly assigned 245 patients to receive in-center daily hemodialysis (6 days per week) or conventional hemodialysis (3 days per week) and 87 patients to receive home nocturnal hemodialysis (6 nights per week) or conventional hemodialysis, for 12 months. The primary vascular access outcome was time to first access event (repair, loss, or access-related hospitalization). Secondary outcomes were time to all repairs and time to all losses. In the Daily Trial, 77 (31%) of 245 patients had a primary outcome event: 33 repairs and 15 losses in the daily group and 17 repairs, 11 losses, and 1 hospitalization in the conventional group. Overall, the risk for a first access event was 76% higher with daily hemodialysis than with conventional hemodialysis (hazard ratio [HR], 1.76; 95% confidence interval [CI], 1.11-2.79; P=0.017); among the 198 patients with an arteriovenous (AV) access at randomization, the risk was 90% higher with daily hemodialysis (HR, 1.90; 95% CI, 1.11-3.25; P=0.02). Daily hemodialysis patients had significantly more total AV access repairs than conventional hemodialysis patients (P=0.011), with 55% of all repairs involving thrombectomy or surgical revision. Losses of AV access did not differ between groups (P=0.58). We observed similar trends in the Nocturnal Trial, although the results were not statistically significant. In conclusion, frequent hemodialysis increases the risk of vascular access complications. The nature of the AV access repairs suggests that this risk likely results from increased hemodialysis frequency rather than heightened surveillance.

Indexed as

AdultAgedArteriovenous Shunt, SurgicalCatheterizationFemaleHemodialysis, HomeHumansMaleMiddle AgedRenal DialysisRisk FactorsVascular Access Devices

Identifiers

PMID23393319
PMCPMC3582201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.